News & Perspective

Mar 01, 2011

Mar 01, 2011

HHS awards two contracts for recombinant flu vaccines

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced that it has awarded $215 million in contracts to two companies to further the development of recombinant technology, a move designed to improve and speed production of pandemic and seasonal flu vaccines.

Mar 02, 2011

Mar 02, 2011

Study finds H1N1 and H9N2 offspring can be more lethal

(CIDRAP News) – Chinese researchers who tested reassortants that combined the 2009 H1N1 virus with H9N2, a subtype that commonly circulates in birds, found that several were more pathogenic then the parent viruses, which they said could pose a pandemic threat.

Mar 03, 2011

Mar 03, 2011

GAO's federal duplication report cites problems in public health

(CIDRAP News) – In the first of an expected annual series of reports to Congress on duplication in federal government goals and activities, the US Government Accountability Office (GAO) cites problems in three areas of public health: food safety, biodefense, and communications.

Mar 04, 2011

Mar 04, 2011

New CDC guidelines profile challenge of norovirus

(CIDRAP News) – A new report from the Centers for Disease Control and Prevention (CDC) makes clear why norovirus is the world's leading cause of gastroenteritis and the leading cause of foodborne disease outbreaks in the United States.

The virus is so contagious that one food handler with contaminated hands can infect hundreds of people, the report says. Those who have had the virus may have little protection against future infection.

Mar 04, 2011

US flu season still going strong

(CIDRAP News) – The nation's flu activity remained high last week, with the number of pediatric deaths more than doubling from the previous week and most states still reporting widespread cases, the US Centers for Disease Control and Prevention (CDC) said today.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»